| Trial ID: | L1443 |
| Source ID: | NCT00939952
|
| Associated Drug: |
Ertapenem
|
| Title: |
Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00939952/results
|
| Conditions: |
Continuous Ambulatory Peritoneal Dialysis|End Stage Renal Disease
|
| Interventions: |
DRUG: ertapenem
|
| Outcome Measures: |
Primary: Volume of Distribution, Central Compartment (Vc), Population PK, 12h|Clearance (CL), population PK clearance, 12h|k12, 1st order intercompartmental rate constant between central and peripheral compartments, 12h|k21, 1st order intercompartmental rate constant from peripheral to central compartment, 12h|k13, 1st order intercompartmental rate constant from central to peritoneal cavity, 12h|k31, 1st order intercompartmental rate constant peritoneal cavity to central, 12h|Residual Drug in Peritoneal Cavity After 1st Exchange, 6h |
|
| Sponsor/Collaborators: |
Sponsor: Albany College of Pharmacy and Health Sciences | Collaborators: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
7
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
|
| Start Date: |
2009-06
|
| Completion Date: |
2010-05
|
| Results First Posted: |
2013-02-26
|
| Last Update Posted: |
2013-02-26
|
| Locations: |
Hortense and Louis Rubin Dialysis Center, Clifton Park, New York, 12065, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00939952
|
